The following is a list of selected recently published Expert Opinion articles, related to the content of this issue of Expert Opinion on Therapeutic Targets:
Selective cannabinoid receptor 2 modulators: a patent review 2009 – present Doris Riether May 2012, Vol. 22, No. 5, Pages 495-510 (doi:10.1517/13543776.2012.682570)
Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists David R. Janero March 2012, Vol. 17, No. 1, Pages 17-29 (doi:10.1517/14728214.2012.660916)
Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point? Petra M Meiners, Arjan Vissink, Cees GM Kallenberg, Frans GM Kroese & Hendrika Bootsma October 2011, Vol. 11, No. 10, Pages 1381-1394 (doi:10.1517/14712598.2011.605352)
Biological therapies in primary Sjögren's syndrome Wan-Fai Ng & Simon J Bowman July 2011, Vol. 11, No. 7, Pages 921-936 (doi:10.1517/14712598.2011.574120)
Implications of endoplasmic reticulum stress, the unfolded protein response and apoptosis for molecular cancer therapy. Part II: targeting cell cycle events, caspases, NF-κB and the proteasome Donavon C Hiss & Gary A Gabriels September 2009, Vol. 4, No. 9, Pages 907-921 (doi:10.1517/17460440903055032)
Implications of endoplasmic reticulum stress, the unfolded protein response and apoptosis for molecular cancer therapy. Part I: targeting p53, Mdm2, GADD153/CHOP, GRP78/BiP and heat shock proteins Donavon C Hiss & Gary A Gabriels August 2009, Vol. 4, No. 8, Pages 799-821 (doi:10.1517/17460440903052559)